Dr. David Sas, DO

NPI: 1922067776
Total Payments
$22,181
2024 Payments
$2,957
Companies
6
Transactions
22

Payment Breakdown by Category

Consulting$16,755 (75.5%)
Other$4,145 (18.7%)
Travel$754.67 (3.4%)
Food & Beverage$520.38 (2.3%)
Education$5.90 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $16,755 7 75.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,050 1 18.3%
Travel and Lodging $754.67 2 3.4%
Food and Beverage $520.38 6 2.3%
Grant $95.00 1 0.4%
Education $5.90 5 0.0%

Top Paying Companies

Company Total Records Latest Year
Alnylam Pharmaceuticals Inc. $12,430 3 $0 (2022)
Retrophin, Inc. $4,093 9 $0 (2019)
Novo Nordisk Inc $2,816 5 $0 (2024)
Novo Nordisk Health Care AG $2,745 3 $0 (2024)
BOSTON SCIENTIFIC CORPORATION $95.00 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,957 5 Novo Nordisk Health Care AG ($2,745)
2023 $2,604 3 Novo Nordisk Inc ($2,604)
2022 $4,060 1 Alnylam Pharmaceuticals Inc. ($4,060)
2021 $4,322 2 Alnylam Pharmaceuticals Inc. ($4,320)
2020 $4,050 1 Alnylam Pharmaceuticals Inc. ($4,050)
2019 $3,417 4 Retrophin, Inc. ($3,417)
2018 $768.36 3 Retrophin, Inc. ($673.36)
2017 $2.82 3 Retrophin, Inc. ($2.82)

All Payment Transactions

22 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/26/2024 Novo Nordisk Health Care AG Food and Beverage In-kind items and services $44.52 General
10/05/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $93.88 General
06/07/2024 Novo Nordisk Health Care AG Consulting Fee Cash or cash equivalent $1,800.00 General
06/07/2024 Novo Nordisk Health Care AG Consulting Fee Cash or cash equivalent $900.00 General
01/26/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $118.50 General
11/05/2023 Novo Nordisk Inc Consulting Fee Cash or cash equivalent $2,137.50 General
11/05/2023 Novo Nordisk Inc Consulting Fee Cash or cash equivalent $337.50 General
11/05/2023 Novo Nordisk Inc Food and Beverage In-kind items and services $128.96 General
03/03/2022 Alnylam Pharmaceuticals Inc. OXLUMO (Drug) Consulting Fee Cash or cash equivalent $4,060.00 General
Category: Genetic Disease
06/30/2021 Travere Therapeutics, Inc. Thiola (Drug) Education In-kind items and services $1.92 General
Category: Kidney Stones
01/13/2021 Alnylam Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $4,320.00 General
11/20/2020 Alnylam Pharmaceuticals Inc. OXLUMO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,050.00 General
Category: Genetic Disease
03/14/2019 Retrophin, Inc. (815) Thiola (Drug) Consulting Fee Cash or cash equivalent $3,200.00 General
Category: Kidney Stones
03/14/2019 Retrophin, Inc. (815) Thiola (Drug) Travel and Lodging Cash or cash equivalent $82.47 General
Category: Kidney Stones
03/14/2019 Retrophin, Inc. (815) Thiola (Drug) Food and Beverage Cash or cash equivalent $48.28 General
Category: Kidney Stones
01/29/2019 Retrophin, Inc. (815) Thiola (Drug) Food and Beverage In-kind items and services $86.24 General
Category: Kidney Stones
12/28/2018 Retrophin, Inc. (815) Thiola (Drug) Travel and Lodging Cash or cash equivalent $672.20 General
Category: Kidney Stones
08/23/2018 Retrophin, Inc. (815) Thiola (Drug) Education In-kind items and services $1.16 General
Category: Kidney Stones
04/25/2018 BOSTON SCIENTIFIC CORPORATION GENERAL KIDNEY STONE DISEASE (Device) Grant Cash or cash equivalent $95.00 General
Category: KIDNEY STONE DISEASE
11/17/2017 Retrophin, Inc. (815) Thiola (Drug) Education In-kind items and services $0.94 General
Category: Kidney Stones
06/08/2017 Retrophin, Inc. (815) Thiola (Drug) Education In-kind items and services $0.94 General
Category: Kidney Stones
03/27/2017 Retrophin, Inc. (815) Thiola (Drug) Education In-kind items and services $0.94 General
Category: Kidney Stones

About Dr. David Sas, DO

Dr. David Sas, DO is a Pediatrics healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922067776.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Sas, DO has received a total of $22,181 in payments from pharmaceutical and medical device companies, with $2,957 received in 2024. These payments were reported across 22 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($16,755).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Pediatric Nephrology, Pediatric Nephrology
  • Location Rochester, MN
  • Active Since 03/21/2006
  • Last Updated 08/20/2020
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1922067776

Products in Payments

  • OXLUMO (Drug) $8,110
  • (815) Thiola (Drug) $4,093
  • GENERAL KIDNEY STONE DISEASE (Device) $95.00
  • Thiola (Drug) $1.92

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Rochester